XIAFLEX hit its Phase 3 goals, but can Keenova change plantar fibromatosis care?
Find out how Keenova’s XIAFLEX Phase 3 success could create the first approved drug for plantar fibromatosis.
Pharma & Biotech
Find out how Keenova’s XIAFLEX Phase 3 success could create the first approved drug for plantar fibromatosis.